“Building a strong research ecosystem is key to advancing the next generation of ultrasound diagnostics,” says Gerald Pötzsch, CEO of ContextVision. “By bringing together top-tier academic expertise and industry-leading technological capabilities, we are creating the foundation for breakthrough innovations in liver disease quantification. These partnerships mark the beginning of a growing network that will expand further in the near future.”

University of Waterloo and InPhase Solutions

ContextVision has signed a research agreement with the University of Waterloo’s Laboratory on Innovative Technology in Medical Ultrasound (LITMUS) in Canada. This collaboration will augment technical and clinical expertise in ultrasound to evolve advanced liver imaging, states the company.

“This partnership is an excellent example of academia and industry working together to bring potentially life-changing solutions to clinical practice,” says Alfred Yu, principal investigator of LITMUS and a professor of biomedical engineering in Waterloo’s Faculty of Engineering.

Additionally, the company has partnered with InPhase Solutions, a Norway-based expert in ultrasound technology development and consultancy. InPhase will provide specialized support to enhance ContextVision’s internal R&D efforts, strengthening its capabilities in quantitative imaging and AI-powered ultrasound technologies.

“This project connects all the right dots: the increasing importance of easy-access liver disease diagnostics, a state-of-the-art ultrasonic dataset, and AI-based analysis,” says Marco M. Voormolen, CEO of InPhase Solutions.